These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19118282)
1. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy. Touyz RM; Callera GE Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282 [No Abstract] [Full Text] [Related]
2. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868 [TBL] [Abstract][Full Text] [Related]
3. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts. Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451 [TBL] [Abstract][Full Text] [Related]
4. A new HOPE for aldosterone blockade? Pitt B Circulation; 2004 Sep; 110(13):1714-6. PubMed ID: 15451807 [No Abstract] [Full Text] [Related]
5. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system. Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132 [TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996 [TBL] [Abstract][Full Text] [Related]
7. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520 [TBL] [Abstract][Full Text] [Related]
8. [Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors]. Nishiyama A Yakugaku Zasshi; 2012; 132(4):455-9. PubMed ID: 22465922 [TBL] [Abstract][Full Text] [Related]
9. Vascular actions of aldosterone. Briet M; Schiffrin EL J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373 [TBL] [Abstract][Full Text] [Related]
10. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling]. Tatsumi T; Matsubara H Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886 [No Abstract] [Full Text] [Related]
11. Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors. Brand S; Amann K; Mandel P; Zimnol A; Schupp N PLoS One; 2014; 9(12):e115715. PubMed ID: 25551569 [TBL] [Abstract][Full Text] [Related]